Results 51 to 60 of about 718 (153)
Metabolic Causes of Epileptic Encephalopathy
Epileptic encephalopathy can be induced by inborn metabolic defects that may be rare individually but in aggregate represent a substantial clinical portion of child neurology. These may present with various epilepsy phenotypes including refractory neonatal seizures, early myoclonic encephalopathy, early infantile epileptic encephalopathy, infantile ...
Joe Yuezhou Yu +2 more
wiley +1 more source
The Neuronal Ceroid Lipofuscinoses (NCLs) comprise a group of around 13 rare degenerative metabolic diseases unified by the accumulation of ceroid-lipofuscin like storage material in the body cells (Mole & Cotman, 2015, Mole et al. 2018). As a group,
Aline Honingh +4 more
core +1 more source
Juvenile neuronal ceroid lipofuscinosis (JNCL) is the result of mutations in the Cln3 gene. The Cln3 knock-in mouse (Cln3Δex7/8) reproduces the most common Cln3 mutation and we have now characterized the CNS of these mice at 12 months of age.
Charlie C. Pontikis +3 more
doaj +1 more source
Background: Juvenile neuronal ceroid lipofuscinosis (JNCL), one of the most frequent forms of the NCL storage diseases, is known to be caused by loss-of-function mutations in ceroid-lipofuscinosis neuronal protein 3 (CLN3), but its cell function has not ...
Jaime Cárcel-Trullols
doaj +1 more source
JNCL-tautia sairastavien nuorten kokemuksia elämästään [PDF]
Tiivistelmä Ikonen, Tatja ja Pihla Tanninen. JNCL-tautia sairastavien nuorten kokemuksia elämästään. Helsinki, kevät 2011, 47 s. Diakonia-ammattikorkeakoulu, Diak Etelä, Helsinki. Hoitotyön koulutusohjelma, sairaanhoitaja (AMK).
Ikonen, Tatja, Tanninen, Pihla
core
Neuronal Ceroid Lipofuscinosis—Concepts, Classification, and Avenues for Therapy
This review comprehensively examined the pathogenic genes associated with various NCL subtypes, elucidating their roles, clinical presentations, corresponding mouse models, and the advances in clinical study of potential therapeutics. In particular, we clarified the potential of novel microglial cell replacement therapies in NCLs, providing hope for ...
Yuheng Zhang +4 more
wiley +1 more source
Insight of autonomic dysfunction in CLN3 disease: a study on episodes resembling paroxysmal sympathetic hyperactivity (PSH). [PDF]
Background Recurrent non-epileptic episodes resembling paroxysmal sympathetic hyperactivity (PSH) have been observed in adolescents with Juvenile Ceroid Lipofuscinosis (CLN3-disease) and a possible association to an autonomic dysfunction has been ...
Baekmann C +5 more
europepmc +2 more sources
Proposed relationship between astrocyte HC activity, brain metabolites, and neuronal loss in JNCL.
Astrocyte HCs are transiently opened in numerous brain regions in the context of CLN3 mutation, which likely distorts the brain metabolome. This is supported by the ability of the HC inhibitor, INI-0602, to reduce lysosomal ceroid inclusions and enhance ...
Juan Xiong (547132) +7 more
core +1 more source
The neuronal ceroid lipofuscinoses (NCL) are a group of inherited, severe neurodegenerative disorders also known as Batten disease. Juvenile NCL (JNCL) is caused by recessive loss-of-function mutations in CLN3, which encodes a transmembrane protein that ...
Robert J Huber +2 more
doaj +1 more source
Juvenile Neuronal Ceroid Lipofuscinosis (JNCL) is a fatal lysosomal storage disease caused by autosomal recessive mutations in CLN3. JNCL is typified by progressive neurodegeneration that has been suggested to occur from excessive excitatory and impaired
Maria Burkovetskaya +2 more
doaj +1 more source

